Literature DB >> 24433825

Resumption of puberty in girls and boys following removal of the histrelin implant.

Marisa M Fisher1, Deborah Lemay2, Erica A Eugster2.   

Abstract

OBJECTIVES: To determine time to menarche in girls and testicular volume increase in boys after removal of a histrelin implant, which causes profound hypothalamic-pituitary-gonadal axis suppression. STUDY
DESIGN: Medical records of patients treated with a histrelin implant were reviewed. Seventy-one patients (56 girls) treated with the histrelin implant were identified, of these patients, 37 explanted girls (68% naïve) and 6 explanted boys (83% naïve) were included in the analysis. Time to menarche after explantation in girls and time to testicular volume increase after explantation in boys were determined. Additional variables investigated included indication for and duration of treatment, history of menarche (girls), previous therapy, and age at beginning and end of histrelin treatment.
RESULTS: Of the girls, 30 were treated for central precocious puberty (CPP), 26 had menarche at an average of 12.75 months after explantation. Of the 30, 7 were treated for other indications, of whom 6 had reached menarche. In girls with CPP, older age at explantation correlated with sooner menarche (P = .04). All boys achieved spontaneous testicular enlargement within 1 year of explantation.
CONCLUSIONS: This study documented resumption of puberty after histrelin explantation in treatment naïve and non-naïve boys and girls with and without CPP. Menarche in girls with CPP occurs within a similar timeframe to that observed after other treatment approaches.
Copyright © 2014 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24433825      PMCID: PMC4096830          DOI: 10.1016/j.jpeds.2013.12.009

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  18 in total

1.  Menstrual cycle pattern during the first gynaecological years in girls with precocious puberty following gonadotropin-releasing hormone analogue treatment.

Authors:  Teresa Arrigo; Filippo De Luca; Franco Antoniazzi; Fiorella Galluzzi; Lorenzo Iughetti; Anna Maria Pasquino; Maria Carolina Salerno; Lucia Marseglia; Giuseppe Crisafulli
Journal:  Eur J Pediatr       Date:  2006-08-12       Impact factor: 3.183

2.  Current concepts in normal and abnormal puberty.

Authors:  Todd D Nebesio; Erica A Eugster
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2007-02

3.  The histrelin implant: a novel treatment for central precocious puberty.

Authors:  Harry J Hirsch; David Gillis; David Strich; Boris Chertin; Amicur Farkas; Tzina Lindenberg; Hadassa Gelber; Irving M Spitz
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

4.  Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese Study Group on Central Precocious Puberty.

Authors:  Toshiaki Tanaka; Hiroo Niimi; Nobutake Matsuo; Kenji Fujieda; Katsuhiko Tachibana; Kenji Ohyama; Mari Satoh; Koji Kugu
Journal:  J Clin Endocrinol Metab       Date:  2004-12-14       Impact factor: 5.958

Review 5.  Treatment and outcomes of precocious puberty: an update.

Authors:  John S Fuqua
Journal:  J Clin Endocrinol Metab       Date:  2013-03-20       Impact factor: 5.958

6.  Time to menarche and final height after histrelin implant treatment for central precocious puberty.

Authors:  David Gillis; Gilad Karavani; Harry J Hirsch; David Strich
Journal:  J Pediatr       Date:  2013-02-26       Impact factor: 4.406

7.  Reproductive outcome in patients treated and not treated for idiopathic early puberty: long-term results of a randomized trial in adults.

Authors:  Alessandra Cassio; Milva O Bal; Luigi F Orsini; Antonio Balsamo; Silvia Sansavini; Monia Gennari; Enrico De Cristofaro; Alessandro Cicognani
Journal:  J Pediatr       Date:  2006-10       Impact factor: 4.406

8.  Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: a multicenter trial.

Authors:  Erica A Eugster; William Clarke; Gad B Kletter; Peter A Lee; E Kirk Neely; Edward O Reiter; Paul Saenger; Dorothy Shulman; Lawrence Silverman; Lisa Flood; William Gray; David Tierney
Journal:  J Clin Endocrinol Metab       Date:  2007-02-27       Impact factor: 5.958

Review 9.  Consensus statement on the use of gonadotropin-releasing hormone analogs in children.

Authors:  Jean-Claude Carel; Erica A Eugster; Alan Rogol; Lucia Ghizzoni; Mark R Palmert; Franco Antoniazzi; Sheri Berenbaum; Jean-Pierre Bourguignon; George P Chrousos; Joël Coste; Sheri Deal; Liat de Vries; Carol Foster; Sabine Heger; Jack Holland; Kirsi Jahnukainen; Anders Juul; Paul Kaplowitz; Najiba Lahlou; Mary M Lee; Peter Lee; Deborah P Merke; E Kirk Neely; Wilma Oostdijk; Moshe Phillip; Robert L Rosenfield; Dorothy Shulman; Dennis Styne; Maïthé Tauber; Jan M Wit
Journal:  Pediatrics       Date:  2009-03-30       Impact factor: 7.124

10.  Results of a second year of therapy with the 12-month histrelin implant for the treatment of central precocious puberty.

Authors:  Samar Rahhal; William L Clarke; Gad B Kletter; Peter A Lee; E Kirk Neely; Edward O Reiter; Paul Saenger; Dorothy Shulman; Lawrence Silverman; Erica A Eugster
Journal:  Int J Pediatr Endocrinol       Date:  2009-02-26
View more
  4 in total

1.  Long-Term Continuous Suppression With Once-Yearly Histrelin Subcutaneous Implants for the Treatment of Central Precocious Puberty: A Final Report of a Phase 3 Multicenter Trial.

Authors:  Lawrence A Silverman; E Kirk Neely; Gad B Kletter; Katherine Lewis; Surya Chitra; Oksana Terleckyj; Erica A Eugster
Journal:  J Clin Endocrinol Metab       Date:  2015-03-24       Impact factor: 5.958

2.  Transgender Youth Experiences with Implantable GnRH Agonists for Puberty Suppression.

Authors:  Brianna J Hobson; Elle Lett; Linda A Hawkins; Robert A Swendiman; Michael L Nance; Nadia L Dowshen
Journal:  Transgend Health       Date:  2022-08-01

3.  Central Precocious Puberty: Update on Diagnosis and Treatment.

Authors:  Melinda Chen; Erica A Eugster
Journal:  Paediatr Drugs       Date:  2015-08       Impact factor: 3.022

4.  Gonadotropin Suppression for 7 Years After a Single Histrelin Implant for Precocious Puberty.

Authors:  Douglas Villalta; Jose B Quintos
Journal:  J Endocr Soc       Date:  2022-01-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.